One drug, 166 patents and $208-billion sales
Down To Earth|March 01, 2023
Arthritis drug Humira is a stark example of how the US patent regime allows drug firms to drain patients and the health system
One drug, 166 patents and $208-billion sales

ONE'S HEART bleeds for American patients. They pay the most for prescription drugs compared to all other jurisdictions despite many ironies: a very large number of life-saving drugs are discovered by public-funded research in US universities and institutions; these pharmaceuticals are made in the US and by leading US-based manufacturers. Why is this so? It is because of a clutch of related reasons starting with the fact that there is no regulation of drug prices by the government but most of all, from exploiting a patent system that allows pharma companies to keep out competition and keep prices sky high. That's the root of the problem.

A case study of how drug companies manipulate the patent regime is AbbVie with its blockbuster anti-inflammation and arthritis drug Humira. The pharma giant has created a patent thicket around this top-selling biological medicine, by applying for an incredible 312 patents on this single drug and obtaining 166! And most of these patents (94 per cent) were sought after the drug was approved by the authorities. This has allowed AbbVie to garner revenues of US $208 billion since the patent was first granted in 2002. But here's the most disturbing aspect of Humira: two-thirds of this revenue was earned after its primary patents expired in 2016.

That was when patients and health insurance companies that pick up the tab for the drug were hoping to benefit from the less expensive biosimilar versions of the drug that were all set to launch in the US. But it did not happen. By shrewdly exploiting the US patent system, AbbVie blocked competitors from entering the market by using lawsuits against potential competitors and forcing them to accept settlements to delay their entry till 2023. The first of the biosimilar versions of Humira has only now been launched in the US, in February 2023-almost seven years after patent expiry.

هذه القصة مأخوذة من طبعة March 01, 2023 من Down To Earth.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة March 01, 2023 من Down To Earth.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من DOWN TO EARTH مشاهدة الكل
A SPRIG TO CARE FOR
Down To Earth

A SPRIG TO CARE FOR

Punarnava, a perennial herb, is easy to grow and has huge health benefits

time-read
3 mins  |
November 01, 2024
DIGGING A DISASTER
Down To Earth

DIGGING A DISASTER

Soapstone mining near Dabti Vijaypur village has caused many residents to migrate.

time-read
2 mins  |
November 01, 2024
REVIEW THE TREATMENT
Down To Earth

REVIEW THE TREATMENT

Several faecal sludge treatment plants in Uttar Pradesh suffer from design flaws that make the treatment process both expensive and inefficient

time-read
3 mins  |
November 01, 2024
MAKE STEEL SUSTAINABLE
Down To Earth

MAKE STEEL SUSTAINABLE

As India works to double its GDP by 2030, its steel industry must balance growth with sustainability. By embracing policies like the Steel Scrap Recycling Policy 2019 and adopting green technologies, India is paving the way for a more sustainable future in steel production

time-read
4 mins  |
November 01, 2024
Can ANRF pull off the impossible for India?
Down To Earth

Can ANRF pull off the impossible for India?

Anusandhan National Research Foundation is expected to reorient India's innovation goals but funding issues, old mindsets remain a drag

time-read
4 mins  |
November 01, 2024
TROUBLED WOODS
Down To Earth

TROUBLED WOODS

Forests are a great bulwark against climate change. But this is fast changing. AKSHIT SANGOMLA travels through some of the pristine patches of the Western Ghats to explore how natural disturbances triggered by global warming now threaten the forest health

time-read
10+ mins  |
November 01, 2024
BLINDING GLOW
Down To Earth

BLINDING GLOW

The science is clear: increased illumination has damaging consequences for the health of humans, animals and plants. It’s time governments introduced policies to protect the natural darkness and improved the quality of outdoor lighting.

time-read
10+ mins  |
November 01, 2024
GROUND REALITY
Down To Earth

GROUND REALITY

What happens when the soil loses the ability to grow healthy, high-yield crops on its own?

time-read
6 mins  |
November 01, 2024
GM POLICY MUST BE FARMER CENTRIC
Down To Earth

GM POLICY MUST BE FARMER CENTRIC

On July 23, the Supreme Court of India directed the Union government to develop a national policy on genetically modified (GM) crops for research, cultivation, trade and commerce through public consultation.

time-read
6 mins  |
November 01, 2024
Vinchurni's Gandhi
Down To Earth

Vinchurni's Gandhi

A 96-year-old farmer transforms barren land into a thriving forest in drought-prone region of Satara

time-read
2 mins  |
November 01, 2024